Home/Pipeline/SOLACE™

SOLACE™

Spinal Fusion

CommercialActive

Key Facts

Indication

Spinal Fusion

Phase

Commercial

Status

Active

Company

Xenix Medical

About Xenix Medical

Xenix Medical is a private, commercial-stage medical device company targeting the spinal fusion surgery market with its innovative implant portfolio. Its technology platform centers on two key innovations: the neoWave™ 3D-printed titanium matrix, which reduces stiffness and disperses load, and the NANOACTIV™ nano-textured surface, designed to enhance osseointegration. The company has FDA-cleared products and appears to be in an early revenue phase, commercializing devices for cervical, lumbar, and sacroiliac fusion procedures. Its strategy is to differentiate through engineering and biomaterial science in a crowded, competitive market dominated by large orthopedics firms.

View full company profile

Therapeutic Areas

Spinal Disorders Degenerative Spine Disease

Other Spinal Fusion Drugs

Drug	Company	Phase	Status
JAZBI™ Cubes	SDIP Innovations	Preclinical	Active
Expandable Interbody Portfolio	Globus Medical	Iterative Development	Active
Mimetic Metal Technology Development	CoreLink Surgical	Development/Commercial	Active
Bone Graft Substitute	BiologicsMD	Pre-clinical	Active
VisuALIF	SpineSmith	Commercial	Active
ASTRO Registry	Artoss	Post-Market	Active
Hive Smart Implant Exploration	NanoHive Medical	Pre-clinical R&D	Active
ProLift Pivot Expandable Spacer System	Life Spine	FDA Cleared	Active
NEXXT MATRIXX Clinical Evidence Study	Nexxt Spine	Post-Market Study	Active
AGA111	Angitia Biopharmaceuticals	Phase 3	Active
X-PAC® Portfolio Expansion	Expanding Innovations	Development	Active
TrellOss Porous Ti Interbody System	HighRidge Medical	Approved	Active